Stock CORIUM
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

CORIUM Stock Nasdaq

Equities

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for CORIUM
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site

Press releases CORIUM

Corium, Inc. Announces FDA Filing Acceptance of New Drug Application for ADLARITY® (donepezil transdermal system) for the Treatment of Alzheimer’s Disease GL
Corium Appoints Perry Sternberg as Chief Executive Officer GL
Corium Announces Offer to Purchase for Cash Any and All of the $120,000,000 Aggregate Outstanding Principal Amount of 5.00% Convertible Senior Notes due 2025 GL
Corium International : RM LAW Announces Investigation of Corium International, Inc. PR
Corium Announces Agreement for Gurnet Point Capital to Purchase All Outstanding Shares GL
More press releases

Managers and Directors - CORIUM

Managers TitleAgeSince
Perry J. Sternberg CEO
 Chief Executive Officer 55 19-03-31
John Miller DFI
 Director of Finance/CFO - -
Charles Oh CTO
 Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Brooks William Andrews BRD
 Director/Board Member - -
David S. Moore BRD
 Director/Board Member 50 -
Perry J. Sternberg
55 -
More insiders

Company Profile

More about the company

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.65% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 194B
AMGEN INC. Stock Amgen Inc.
+8.08% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW